Zehua Wang Selected Research

Zehua Wang Research Topics

Disease

85	Neoplasms (Cancer) 10/2022 - 01/2002
41	Ovarian Neoplasms (Ovarian Cancer) 09/2021 - 01/2004
28	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 01/2005
17	Ovarian Epithelial Carcinoma 01/2021 - 04/2003
11	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2005
9	Breast Neoplasms (Breast Cancer) 10/2020 - 01/2006
9	Carcinogenesis 10/2020 - 10/2010
5	Infections 01/2020 - 12/2002
4	Lymphatic Metastasis 10/2021 - 08/2011
4	Carcinoma (Carcinomatosis) 12/2020 - 03/2010
4	Prostatic Neoplasms (Prostate Cancer) 11/2016 - 02/2012
3	Uterine Cervical Dysplasia 01/2017 - 01/2005
2	Liver Neoplasms (Liver Cancer) 01/2022 - 01/2017
2	Inflammation (Inflammations) 01/2022 - 01/2017
2	Stomach Neoplasms (Stomach Cancer) 01/2022 - 11/2021
2	COVID-19 01/2021 - 01/2020
2	Pathologic Processes 01/2021 - 04/2013
2	Lung Neoplasms (Lung Cancer) 12/2020 - 02/2017
2	Hemorrhage 01/2020 - 09/2011
2	Disease Progression 02/2019 - 01/2014
2	Pre-Eclampsia (Preeclampsia) 04/2017 - 02/2004
2	Ascites 11/2015 - 01/2002
2	Endometrial Neoplasms (Endometrial Cancer) 06/2010 - 06/2008
1	Pain (Aches) 12/2021
1	Esophageal Neoplasms (Esophageal Cancer) 02/2021
1	Persistent Infection 01/2021

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2006
17	Cisplatin (Platino)FDA LinkGeneric 09/2021 - 01/2004
13	PlatinumIBA 09/2021 - 07/2005
10	Pharmaceutical PreparationsIBA 09/2021 - 10/2010
10	Biomarkers (Surrogate Marker)IBA 10/2020 - 08/2013
10	Messenger RNA (mRNA)IBA 06/2019 - 02/2004
9	MicroRNAs (MicroRNA)IBA 01/2022 - 10/2010
9	Paclitaxel (Taxol)FDA LinkGeneric 09/2021 - 07/2005
7	Biological ProductsIBA 10/2022 - 01/2002
7	Small Interfering RNA (siRNA)IBA 11/2021 - 01/2006
6	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2004
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2017 - 10/2009
5	Long Noncoding RNAIBA 01/2021 - 01/2018
5	Enhancer of Zeste Homolog 2 ProteinIBA 06/2018 - 04/2013
4	VimentinIBA 10/2021 - 08/2011
4	Cadherins (E-Cadherin)IBA 10/2021 - 12/2010
4	EnzymesIBA 11/2018 - 10/2009
4	Matrix Metalloproteinases (MMPs)IBA 01/2017 - 06/2009
3	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 01/2018
3	Lactic Acid (Lactate)FDA LinkGeneric 11/2021 - 11/2019
3	Indicators and Reagents (Reagents)IBA 10/2021 - 01/2005
3	olaparibIBA 09/2021 - 03/2019
3	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2006
3	HeterochromatinIBA 01/2021 - 03/2019
3	CytokinesIBA 01/2020 - 12/2002
3	AngiopoietinsIBA 01/2020 - 01/2017
3	Voltage-Gated Sodium ChannelsIBA 02/2019 - 02/2009
3	Conditioned Culture MediaIBA 12/2017 - 11/2014
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022 - 01/2020
2	Epidermal Growth Factor (EGF)IBA 01/2022 - 01/2020
2	Angiopoietin-2IBA 01/2022 - 01/2017
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 09/2021 - 03/2019
2	Therapeutic UsesIBA 02/2021 - 12/2020
2	Estrogen ReceptorsIBA 10/2020 - 09/2013
2	TOR Serine-Threonine KinasesIBA 10/2020 - 06/2008
2	Histones (Histone)IBA 01/2020 - 10/2010
2	ImmunosorbentsIBA 01/2017 - 10/2009
2	Androgen Receptors (Androgen Receptor)IBA 11/2016 - 02/2012
2	Lysine (L-Lysine)FDA Link 11/2016 - 10/2010
2	MethyltransferasesIBA 01/2016 - 10/2010
2	Carboplatin (JM8)FDA LinkGeneric 01/2015 - 03/2012
2	CateninsIBA 04/2014 - 08/2011
2	Histone MethyltransferasesIBA 03/2014 - 01/2014
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 09/2013 - 01/2013
2	UbiquitinIBA 09/2013 - 01/2013
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 05/2012 - 10/2010
2	CXCR4 Receptors (CXCR4 Receptor)IBA 08/2011 - 06/2009
2	CollagenIBA 06/2009 - 01/2006
2	Caspase 3 (Caspase-3)IBA 01/2006 - 01/2005
2	SurvivinIBA 07/2005 - 01/2005
2	cloricromen (AD 6)IBA 03/2005 - 01/2004
1	LigandsIBA 01/2022
1	Dexmedetomidine FDA Link 12/2021
1	Sincalide FDA Link 11/2021
1	Fluorouracil (Carac)FDA LinkGeneric 11/2021
1	Antineoplastic Agents (Antineoplastics)IBA 09/2021
1	CRISPR-Associated Protein 9IBA 01/2021
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021
1	NAD (NADH)IBA 01/2021
1	OxysterolsIBA 01/2021

Therapy/Procedure

20	Drug Therapy (Chemotherapy) 09/2021 - 04/2003
14	Therapeutics 01/2022 - 02/2012
10	Hysterectomy 01/2022 - 06/2010
8	Lymph Node Excision (Lymph Node Dissection) 10/2021 - 04/2003
5	Neoadjuvant Therapy 01/2020 - 07/2012
3	Radiotherapy 10/2021 - 03/2012
2	Immunotherapy 01/2022 - 01/2021
2	Aftercare (After-Treatment) 03/2012 - 01/2006
1	Adjuvant Chemotherapy 01/2022
1	Gastrectomy 01/2022
1	Minimally Invasive Surgical Procedures 01/2022
1	Radiofrequency Ablation 01/2022
1	Cytoreduction Surgical Procedures 09/2021
1	Drug Tapering 09/2021